Cargando…

Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells

Cancer therapy is limited by toxicity in normal cells and drug-resistance in cancer cells. Paradoxically, cancer resistance to certain therapies can be exploited for protection of normal cells, simultaneously enabling the selective killing of resistant cancer cells by using antagonistic drug combina...

Descripción completa

Detalles Bibliográficos
Autor principal:	Blagosklonny, Mikhail V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010629/ https://www.ncbi.nlm.nih.gov/pubmed/36913303 http://dx.doi.org/10.18632/oncotarget.28382

Ejemplares similares

Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture
por: Apontes, Pasha, et al.
Publicado: (2011)

Wt p53 impairs response to chemotherapy: make lemonade to spare normal cells
por: Blagosklonny, Mikhail V.
Publicado: (2012)

Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells
por: Goldberg, Alexander A., et al.
Publicado: (2011)

Selective anti-cancer agents as anti-aging drugs
por: Blagosklonny, Mikhail V
Publicado: (2013)

While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblasts
por: Leontieva, Olga V., et al.
Publicado: (2017)

T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes
por: Ali, Muhammad, et al.
Publicado: (2021)

DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence
por: Leontieva, Olga V., et al.
Publicado: (2010)

Protecting the normal in order to better kill the cancer
por: Liu, Bingya, et al.
Publicado: (2015)

Cell killing and resistance in pre-operative breast cancer chemotherapy
por: Ubezio, Paolo, et al.
Publicado: (2008)

Progeria, rapamycin and normal aging: recent breakthrough
por: Blagosklonny, Mikhail V.
Publicado: (2011)

Protecting normal cells from the cytotoxicity of chemotherapy
por: Cheok, Chit Fang
Publicado: (2012)

JP3 enhances the toxicity of cisplatin on drug-resistant gastric cancer cells while reducing the damage to normal cells
por: Zhang, Yi, et al.
Publicado: (2021)

Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions
por: Blagosklonny, Mikhail V.
Publicado: (2012)

Irradiation Can Selectively Kill Tumor Cells while Preserving Erythrocyte Viability in a Co-Culture System
por: Gong, Ming, et al.
Publicado: (2015)

Photochemical internalisation of chemotherapy potentiates killing of multidrug-resistant breast and bladder cancer cells
por: Adigbli, D K, et al.
Publicado: (2007)

Integrating Enzymatic Self-Assembly and Mitochondria Targeting for Selectively Killing Cancer Cells without Acquired Drug Resistance
por: Wang, Huaimin, et al.
Publicado: (2016)

Validation of anti-aging drugs by treating age-related diseases
por: Blagosklonny, Mikhail V.
Publicado: (2009)

Cell cycle arrest is not senescence
por: Blagosklonny, Mikhail V.
Publicado: (2011)

Rejuvenating immunity: “anti-aging drug today” eight years later
por: Blagosklonny, Mikhail V.
Publicado: (2015)

Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging
por: Blagosklonny, Mikhail V.
Publicado: (2012)

Cell senescence, rapamycin and hyperfunction theory of aging
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Chemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill.
por: Wilbur, D. W., et al.
Publicado: (1992)

CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: Duration of cell cycle arrest and MTOR activity determine geroconversion
por: Leontieva, Olga V, et al.
Publicado: (2013)

Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to
por: Blagosklonny, Mikhail V.
Publicado: (2012)

Tissue-selective therapy of cancer
por: Blagosklonny, M V
Publicado: (2003)

Cellular senescence: when growth stimulation meets cell cycle arrest
por: Blagosklonny, Mikhail V.
Publicado: (2023)

Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer
por: Salaroglio, Iris C., et al.
Publicado: (2022)

Selective cancer cell killing by α-tocopheryl succinate
por: Neuzil, J, et al.
Publicado: (2001)

Selective killing of cancer cells by nanoparticle-assisted ultrasound
por: Kosheleva, Olga K., et al.
Publicado: (2016)

Gerosuppression in confluent cells
por: Leontieva, Olga V., et al.
Publicado: (2014)

Hydrophilic nanoparticles that kill bacteria while sparing mammalian cells reveal the antibiotic role of nanostructures
por: Jiang, Yunjiang, et al.
Publicado: (2022)

PAN-811 Blocks Chemotherapy Drug-Induced In Vitro Neurotoxicity, While Not Affecting Suppression of Cancer Cell Growth
por: Jiang, Zhi-Gang, et al.
Publicado: (2016)

Cancer prevention with rapamycin
por: Blagosklonny, Mikhail V.
Publicado: (2023)

Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
por: Lamb, Lawrence S., et al.
Publicado: (2013)

From causes of aging to death from COVID-19
por: Blagosklonny, Mikhail V.
Publicado: (2020)

Immunosuppressants in cancer prevention and therapy
por: Blagosklonny, Mikhail V
Publicado: (2013)

Hallmarks of cancer and hallmarks of aging
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Are menopause, aging and prostate cancer diseases?
por: Blagosklonny, Mikhail V.
Publicado: (2023)

Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer
por: DuHadaway, James, et al.
Publicado: (2016)

Histamine H1 receptor antagonists selectively kill cisplatin-resistant human cancer cells
por: Matsumoto, Nobuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dil6fapq0bhni059rs39cdo75a